These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15980617)

  • 21. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
    Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
    Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain Amyloidosis and BDNF Deficiency Have Opposite Effects on Brain Volumes in AβPP/PS1 Mice Both in vivo and ex vivo.
    Kärkkäinen E; Lahtinen HM; Närväinen J; Gröhn O; Tanila H
    J Alzheimers Dis; 2015; 46(4):929-46. PubMed ID: 26402627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
    Matharu B; Spencer N; Howe F; Austen B
    Neuropeptides; 2015 Oct; 53():63-70. PubMed ID: 26234669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
    Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amyloid imaging using high-field magnetic resonance.
    Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I
    Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 19F and 1H MRI detection of amyloid beta plaques in vivo.
    Higuchi M; Iwata N; Matsuba Y; Sato K; Sasamoto K; Saido TC
    Nat Neurosci; 2005 Apr; 8(4):527-33. PubMed ID: 15768036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.
    André S; Ansciaux E; Saidi E; Larbanoix L; Stanicki D; Nonclercq D; Vander Elst L; Laurent S; Muller RN; Burtea C
    J Alzheimers Dis; 2017; 60(4):1547-1565. PubMed ID: 29036827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Framework for 3D histologic reconstruction and fusion with in vivo MRI: Preliminary results of characterizing pulmonary inflammation in a mouse model.
    Rusu M; Golden T; Wang H; Gow A; Madabhushi A
    Med Phys; 2015 Aug; 42(8):4822-32. PubMed ID: 26233209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.
    Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L
    J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
    Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
    Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.
    Zhang J; Yarowsky P; Gordon MN; Di Carlo G; Munireddy S; van Zijl PC; Mori S
    Magn Reson Med; 2004 Mar; 51(3):452-7. PubMed ID: 15004784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
    Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
    Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferred features of a fluorine-19 MRI probe for amyloid detection in the brain.
    Yanagisawa D; Taguchi H; Ibrahim NF; Morikawa S; Shiino A; Inubushi T; Hirao K; Shirai N; Sogabe T; Tooyama I
    J Alzheimers Dis; 2014; 39(3):617-31. PubMed ID: 24246421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease.
    Zeng J; Wu J; Li M; Wang P
    Arch Med Res; 2018 May; 49(4):282-285. PubMed ID: 30266531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
    Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
    Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.
    Ta R; Suchy M; Tam JH; Li AX; Martinez-Santiesteban FS; Scholl TJ; Hudson RH; Bartha R; Pasternak SH
    Contrast Media Mol Imaging; 2013; 8(2):127-39. PubMed ID: 23281285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.
    Blockx I; Einstein S; Guns PJ; Van Audekerke J; Guglielmetti C; Zago W; Roose D; Verhoye M; Van der Linden A; Bard F
    J Alzheimers Dis; 2016 Sep; 54(2):723-35. PubMed ID: 27567811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.